Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Theratechnologies Inc (THTX)
NASDAQ:THTX
Holding THTX?
Track your performance easily
THTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.88 - $2.58
Previous Close$1.42
Volume14.30K
Average Volume (3M)38.65K
Market Cap
$65.30M
Enterprise Value$100.67M
Total Cash (Recent Filing)$22.87M
Total Debt (Recent Filing)$58.24M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Oct 09, 2024EPS Estimate
$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding45,980,019
10 Day Avg. Volume18,500
30 Day Avg. Volume38,646
Standard Deviation0.28
R-Squared0.07
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.56
Price to Sales (P/S)0.78
Price to Cash Flow (P/CF)2.90
P/FCF Ratio1.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.26
Enterprise Value/Gross Profit1.79
Enterprise Value/Ebitda-6.00
Forecast
1Y Price Target
$3.00Price Target Upside111.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Theratechnologies News
PremiumCompany Announcements
Theratechnologies Faces EGRIFTA SV Supply Disruption
PremiumCompany Announcements
Theratechnologies Celebrates Profitable Q2 with Revenue Surge
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCompany's trajectory and transition to sustainable cash flow positivity.
Product DemandHigh patient demand for EGRIFTA SV with sales potentially more than doubling.
Strategic GrowthStable financial position could facilitate BD activity and acquisitions.
Bears Say
Financial Valuation AdjustmentsThe terminal growth rate used in the risk-adjusted discounted cash flow analysis has been reduced.
Product Efficacy ConcernsTrogarzo IM injection did not meet equivalence limits to IV injection.
Regulatory SetbacksThe company received a refusal to file letter from the FDA regarding its sBLA application for Trogarzo.
---
Ownership Overview
40.95% Insiders
0.06% Mutual Funds
25.09% Other Institutional Investors
33.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
THTX FAQ
What was Theratechnologies Inc’s price range in the past 12 months?
Theratechnologies Inc lowest stock price was $0.88 and its highest was $2.58 in the past 12 months.
What is Theratechnologies Inc’s market cap?
Currently, no data Available
When is Theratechnologies Inc’s upcoming earnings report date?
Theratechnologies Inc’s upcoming earnings report date is Oct 09, 2024 which is in 19 days.
How were Theratechnologies Inc’s earnings last quarter?
Theratechnologies Inc released its earnings results on Jul 10, 2024. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of -$0.017 by $0.037.
Is Theratechnologies Inc overvalued?
According to Wall Street analysts Theratechnologies Inc’s price is currently Undervalued.
Does Theratechnologies Inc pay dividends?
Theratechnologies Inc does not currently pay dividends.
What is Theratechnologies Inc’s EPS estimate?
Theratechnologies Inc’s EPS estimate is $0.03.
How many shares outstanding does Theratechnologies Inc have?
Theratechnologies Inc has 45,980,020 shares outstanding.
What happened to Theratechnologies Inc’s price movement after its last earnings report?
Theratechnologies Inc reported an EPS of $0.02 in its last earnings report, beating expectations of -$0.017. Following the earnings report the stock price went down -3.226%.
Which hedge fund is a major shareholder of Theratechnologies Inc?
Currently, no hedge funds are holding shares in THTX
---
Theratechnologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (111.27% Upside)
$3.00 (111.27% Upside)
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.78%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.15%
Trailing 12-Months
Company Description
Theratechnologies Inc
Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.
---
THTX Earnings Call
Q2 2024
0:00 / 0:00
---
THTX Stock 12 Month Forecast
Average Price Target
$3.00
▲(111.27% Upside)
Technical Analysis
Best Analysts Covering THTX
1 Year
1 Year Success Rate
2/12 ratings generated profit
1 Year Average Return
-32.28%
reiterated a buy rating 2 months ago
Copying Justin Walsh's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -32.28% per trade.
---